MediciNova to start Phase ll/lll trial of MN-166 for DCM
MediciNova is set to begin a Phase ll/lll trial to evaluate the efficacy of MN-166 (ibudilast) as an adjuvant treatment…
DCM MediciNova MN-166
MediciNova is set to begin a Phase ll/lll trial to evaluate the efficacy of MN-166 (ibudilast) as an adjuvant treatment…